By expenditures
| Name | Title | Type |
|---|---|---|
| Roy Carlton | CFO | Auditee |
| Jason Flahive | Director | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 361168 | 2023 | 2025-07-01 | Ostrow Reisin Berk & Abrams LTD | $11.74M |
| 327477 | 2022 | 2024-11-06 | Ostrow Reisin Berk & Abrams LTD | $10.96M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 361168 | 2023 | 2025-07-01 | 1146369 | 2023-002 | Significant Deficiency | Yes | L |
| 361168 | 2023 | 2025-07-01 | 1146368 | 2023-002 | Significant Deficiency | Yes | L |
| 361168 | 2023 | 2025-07-01 | 1146367 | 2023-001 | Significant Deficiency | - | L |
| 361168 | 2023 | 2025-07-01 | 1146366 | 2023-001 | Significant Deficiency | - | L |
| 361168 | 2023 | 2025-07-01 | 569927 | 2023-002 | Significant Deficiency | Yes | L |
| 361168 | 2023 | 2025-07-01 | 569926 | 2023-002 | Significant Deficiency | Yes | L |
| 361168 | 2023 | 2025-07-01 | 569925 | 2023-001 | Significant Deficiency | - | L |
| 361168 | 2023 | 2025-07-01 | 569924 | 2023-001 | Significant Deficiency | - | L |
| 327477 | 2022 | 2024-11-06 | 1081245 | 2022-002 | Significant Deficiency | - | L |
| 327477 | 2022 | 2024-11-06 | 1081244 | 2022-002 | Significant Deficiency | - | L |
| 327477 | 2022 | 2024-11-06 | 1081243 | 2022-002 | Significant Deficiency | - | L |
| 327477 | 2022 | 2024-11-06 | 1081242 | 2022-002 | Significant Deficiency | - | L |
| 327477 | 2022 | 2024-11-06 | 1081241 | 2022-002 | Significant Deficiency | - | L |
| 327477 | 2022 | 2024-11-06 | 1081240 | 2022-002 | Significant Deficiency | - | L |
| 327477 | 2022 | 2024-11-06 | 1081239 | 2022-002 | Significant Deficiency | - | L |
| 327477 | 2022 | 2024-11-06 | 504803 | 2022-002 | Significant Deficiency | - | L |
| 327477 | 2022 | 2024-11-06 | 504802 | 2022-002 | Significant Deficiency | - | L |
| 327477 | 2022 | 2024-11-06 | 504801 | 2022-002 | Significant Deficiency | - | L |
| 327477 | 2022 | 2024-11-06 | 504800 | 2022-002 | Significant Deficiency | - | L |
| 327477 | 2022 | 2024-11-06 | 504799 | 2022-002 | Significant Deficiency | - | L |
| 327477 | 2022 | 2024-11-06 | 504798 | 2022-002 | Significant Deficiency | - | L |
| 327477 | 2022 | 2024-11-06 | 504797 | 2022-002 | Significant Deficiency | - | L |